These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10027514)

  • 21. D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients.
    Jones H; Curtis VA; Wright P; Pilowsky LS; Lucey JV
    Psychiatry Res; 2002 Dec; 113(1-2):41-7. PubMed ID: 12467944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
    Park SB; Williamson DJ; Cowen PJ
    Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D,L-fenfluramine challenge test: experience in nonpatient sample.
    Muldoon MF; Manuck SB; Jansma CL; Moore AL; Perel J; Mann JJ
    Biol Psychiatry; 1996 May; 39(9):761-8. PubMed ID: 8731516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ; Kramer J; Hauger RL; Coccaro EF
    Psychiatry Res; 1998 Jul; 79(3):199-205. PubMed ID: 9704866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Am J Psychiatry; 1997 Oct; 154(10):1430-5. PubMed ID: 9326827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychiatry Res; 1999 Dec; 89(2):115-22. PubMed ID: 10646830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms.
    Sharma RP; Singh V; Janicak PG; Javaid JI; Pandey GN
    Schizophr Res; 1999 Aug; 39(1):85-9. PubMed ID: 10480671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.
    Cryan JF; Harkin A; Naughton M; Kelly JP; Leonard BE
    Eur J Pharmacol; 2000 Mar; 390(3):275-85. PubMed ID: 10708734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD; Manuck SB; Perel JM; Muldoon MF
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
    Baumann MH; Ayestas MA; Rothman RB
    J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa.
    Monteleone P; Brambilla F; Bortolotti F; La Rocca A; Maj M
    Br J Psychiatry; 1998 May; 172():439-42. PubMed ID: 9747408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P; Catapano F; Bortolotti F; Maj M
    Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.